A multiomics disease progression signature of low-risk ccRCC

Clear cell renal cell carcinoma (ccRCC) is the most common renal cancer. Identification of ccRCC likely to progress, despite an apparent low risk at the time of surgery, represents a key clinical issue. From a cohort of adult ccRCC patients (n = 443), we selected low-risk tumors progressing within a...

Descripción completa

Detalles Bibliográficos
Autores principales: Strauss, Philipp, Rivedal, Mariell, Scherer, Andreas, Eikrem, Øystein, Nakken, Sigrid, Beisland, Christian, Bostad, Leif, Flatberg, Arnar, Skandalou, Eleni, Beisvåg, Vidar, Furriol, Jessica, Marti, Hans-Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356046/
https://www.ncbi.nlm.nih.gov/pubmed/35931808
http://dx.doi.org/10.1038/s41598-022-17755-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356046/
https://www.ncbi.nlm.nih.gov/pubmed/35931808
http://dx.doi.org/10.1038/s41598-022-17755-2

Ejemplares similares